Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Share-based Compensation (2016 - 2025)

Jaguar Health (JAGX) has disclosed Share-based Compensation for 11 consecutive years, with $135000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation fell 56.45% to $135000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 41.55% decrease, with the full-year FY2024 number at $1.6 million, down 22.3% from a year prior.
  • Share-based Compensation was $135000.0 for Q3 2025 at Jaguar Health, down from $279000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.2 million in Q3 2021 to a low of $135000.0 in Q3 2025.
  • A 5-year average of $610210.5 and a median of $537000.0 in 2023 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 78.44% in 2021, then plummeted 65.24% in 2022.
  • Jaguar Health's Share-based Compensation stood at $1.1 million in 2021, then tumbled by 65.24% to $397000.0 in 2022, then skyrocketed by 45.34% to $577000.0 in 2023, then tumbled by 36.4% to $367000.0 in 2024, then crashed by 63.22% to $135000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Share-based Compensation are $135000.0 (Q3 2025), $279000.0 (Q2 2025), and $301000.0 (Q1 2025).